Cassady Schiller Wealth Management’s Pfizer PFE Stock Holding History

Cassady Schiller Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$73.9K	Sell	2,784 -1,133	-29%	-$30.7K	0.03%	175
2024 Q3	$113K	Sell	3,917 -41	-1%	-$1.2K	0.04%	151
2024 Q2	$111K	Buy	3,958 +807	+26%	+$22.2K	0.05%	150
2024 Q1	$87.4K	Sell	3,151 -1,324	-30%	-$36.7K	0.04%	168
2023 Q4	$129K	Buy	4,475 +226	+5%	+$6.83K	0.06%	133
2023 Q3	$141K	Sell	4,249 -615	-13%	-$21.7K	0.08%	128
2023 Q2	$178K	Buy	4,864 +265	+6%	+$10.3K	0.1%	113
2023 Q1	$188K	Buy	4,599 +100	+2%	+$4.32K	0.09%	106
2022 Q4	$231K	Sell	4,499 -687	-13%	-$32.9K	0.14%	93
2022 Q3	$227K	Buy	5,186 +269	+5%	+$13.1K	0.13%	96
2022 Q2	$258K	Buy	4,917 +202	+4%	+$10.3K	0.14%	88
2022 Q1	$244K	Hold	4,715	–	–	0.12%	95
2021 Q4	$278K	Buy	+4,715	New	+$234K	0.17%	77

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cassady Schiller Wealth Management's PFE Position: Q4 2024 in Review

Cassady Schiller Wealth Management reduced its Pfizer (PFE) stake by 29% in Q4 2024, selling an estimated $30.7K and leaving 2,784 shares worth $73.9K. The position accounts for 0.03% of the portfolio, ranked #175.

Cassady Schiller Wealth Management first reported a position in PFE in Q4 2021 and has held it in 13 quarters since. The position peaked at $278K in Q4 2021. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

Cassady Schiller Wealth Management held 2,784 shares of Pfizer worth $73.9K as of Q4 2024.
Cassady Schiller Wealth Management sold 1,133 Pfizer shares in Q4 2024, an estimated $30.7K.
Pfizer made up 0.03% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #175 holding.
Cassady Schiller Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 13 quarters since.
Cassady Schiller Wealth Management's Pfizer position peaked at $278K in Q4 2021.
2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.